Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Status Terminated

Clinical Trial Summary

The aim of the study if to determine if Iressa can prolong the period of time without any disease worsening (Time to progression) in patients previously treated with combined therapy such as surgery and chemotherapy with or without radiotherapy or chemotherapy and radiotherapy

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00234468
Study type	Interventional
Source	AstraZeneca
Contact
Status	Terminated
Phase	Phase 3
Start date	January 2004
Completion date	August 2007

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01229150` - Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...	Phase 2
Terminated	`NCT00592007` - Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer	Phase 2
Completed	`NCT00199758` - Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer	Phase 2
Completed	`NCT01999738` - Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT01941316` - Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients	Phase 1/Phase 2
Completed	`NCT00111839` - Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer	Phase 2
Completed	`NCT00181532` - Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC	Phase 2
Completed	`NCT00864266` - Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer	N/A
Completed	`NCT00890903` - Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)	N/A
Completed	`NCT00635791` - Phase I Study of Vorinostat and Sorafenib in Advanced Cancer	Phase 1
Recruiting	`NCT00727350` - Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.	Phase 2
Completed	`NCT01209520` - Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy	N/A
Active, not recruiting	`NCT00759382` - Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
Completed	`NCT00087711` - A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer	Phase 3
Completed	`NCT00252798` - ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer	Phase 1
Completed	`NCT02938624` - Anti PD-1 Neo-adjuvant Treatment for NSCLC	Phase 1
Completed	`NCT00608868` - SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients	Phase 4
Terminated	`NCT00661011` - Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy	Phase 2
Completed	`NCT00193921` - Chemoradiotherapy in Patients With Localised Lung Cancer	Phase 2
Completed	`NCT00252746` - ZD6474 Phase IIa Dose Finding Multicentre Study	Phase 2